在帕金森病中,VPS13C异构性功能丧失作为对利沃多巴治疗次优反应的修饰剂
Lorenzo Malfer1, Capucine Piat1, Eduardo E Benarroch1
1Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Parkinsonism & related disorders
|September 26, 2025
概括
VPS13C基因中的致病变体可能会增加早期发病的帕金森病 (EOPD) 风险,并影响非运动症状. 这些遗传变异可能导致EOPD患者对利沃多巴治疗的亚优反应.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- VPS13C基因编码了一种对细胞平衡至关重要的脂质运输蛋白.
- VPS13C突变与早期发病的帕金森病 (PARK23) 和具有勒维体的痴呆症 (DLB) 有关.
- 这种蛋白质对线粒体和 lysosomal 功能至关重要.
研究的目的:
- 介绍四名患有早期发病的帕金森病 (EOPD) 患者的临床病例系列.
- 为了研究EOPD中VPS13C基因中异性致病变体的作用.
- 分析这些患者的临床表型和治疗反应.
主要方法:
- 通过梅奥诊所数据探索器进行病例识别.
- 纳入标准:帕金森病 (PD) 的临床诊断和一种病原性异构VPS13C变种.
- 表型特征包括非运动症状和对levodopa的反应.
主要成果:
- 四位患者都出现了显著的非运动症状:失眠,焦虑,抑郁,疲劳和记忆丧失.
- 利沃多巴治疗初步有好处,但所有患者的反应能力迅速下降.
- 三名患者的DaT-SCAN成像与PD一致;两个患者出现了磨损发作.
结论:
- VPS13C的致病变体可能会增加EOPD的风险,并作为表型修饰剂.
- 这些变体与突出的非运动症状和较差的勒沃多巴反应有关.
- 低于最佳的治疗反应可能与降低多巴胺载体LAT1水平有关.
更多相关视频
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
8.0K
05:51Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
4.4K
相关概念视频
Parkinson's Disease: Treatment
986
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
986
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K
Loss of Tumor Suppressor Gene Functions
5.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.9K
Pleiotropy
43.2K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.2K
